alert icon Coronavirus

Now scheduling COVID-19 vaccine appointments for ages 12+
Schedule a vaccine appointment
COVID-19 vaccine FAQs

Going to a Cleveland Clinic location?
2 visitors (ages 18+) now allowed daily
Masks required for patients and visitors (even if you're vaccinated)

Gary Procop, MD

Gary Procop, MD
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Laboratory Medicine
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Locations Specialties & Treatments

Treatment & Services

  • Infectious Disease Pathology
  • Molecular Diagnostics
  • Molecular Pathology
View all 3 Treatment & Services +

Specialty in Diseases & Conditions

  • General Infectious Diseases
View all 1 Specialties +


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Gary Procop, MD

Dr. Gary W. Procop, MD, MS, is Medical Director and Co-Chair of Cleveland Clinic’s Enterprise Laboratory Stewardship Committee and serves as Director of Molecular Microbiology, Virology, Mycology and Parasitology. He is past Chair of the Departments of Clinical Pathology and Molecular Pathology, and past Section Head for Clinical and Molecular Microbiology.

Dr. Procop has a primary interest in developing and promoting best practices in laboratory testing; the practical applications of molecular diagnostic methods for the diagnosis and treatment of infections; infectious disease pathology; mycology and parasitology. 

Dr. Procop completed his undergraduate degree at Eastern Michigan University, followed by a medical degree and a masters of science degree at Marshall University School of Medicine. He completed residency training in anatomic and clinical pathology at Duke University Medical Center and a clinical Microbiology Fellowship at Mayo Clinic. 

Dr. Procop has given more than 600 scientific presentations, and has 200 published manuscripts, 49 chapters and three books to his credit. He is the Immediate Past President and a Trustee of the American Board of Pathology, and Chair of its Microbiology Test Development Committee. He also is a Member of the NGS Coalition and Conferences Committee for the American Society for Microbiology.

Dr. Procop is past Chair and now Advisor of the Microbiology Resource Committee for the College of American Pathologists. He is also a Member of the Council on Scientific Affairs and Quality Practices Committee for the College. He is also a Member of the Effective Test Utilization Subcommittee of the Commission on Science, Technology and Policy for the American Society for Clinical Pathology. Major recognitions include the ASM BD Award for Research in Clinical Microbiology, the CAP Distinguished Patient Care Award and the ASCP Mastership Designation. 

Dr. Procop is a diplomat of the American Board of Pathology in Anatomic and Clinical Pathology, and Medical Microbiology. He is a Fellow of the American Academy of Microbiology, the College of American Pathologists, the American Society for Clinical Pathology, the Infectious Diseases Society of America, and the Royal Society of Tropical Medicine and Hygiene.

Dr. Procop enjoys sailing, outdoor activities and genealogical research.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Fellowship - Mayo Clinic
Medical Microbiology
Rochester, MN USA

Residency - Duke University Medical Center
Anatomic & Clinical Pathology
Durham, NC USA

Internship - Duke U. School of Medicine
Anatomic & Clinical Pathology
Durham, NC USA

Medical Education - Marshall University School of Medicine
Huntington, WV USA

Undergraduate - Eastern Michigan University
Ypsilanti, MI USA

Graduate School - Marshall University School of Medicine
Huntington, WV USA

Additional Training

  • Director, Clinical Microbiology Fellowship Program, Cleveland Clinic, 1998-2006
  • Statistical Science in Medical Research, 12-Week Course, Cleveland Clinic, 2003
  • NucliSens EasyQ Basic Kit Training Workshop, bioMerieux, Durham, N.C., 2003                 
  • Leading in HealthCare Course, Cleveland Clinic, 2004-2005
  • Applied Biosystems 3130 Genetic Analyzer training, Jackson Memorial Hospital, Miami, Fla., 2007

Professional Highlights

  • Cleveland Clinic Quest for Quality Award; Preoperative nasal mupirocin to reduce colonization and decrease risk of mediastinal infection; Banbury M, Cwynar R, Weber M, Lober C, Gordon SM, Procop GW; 2003 
  • Cleveland Clinic Innovators Award 2004; Identification of mycobacteria by pyrosequencing; 2005        
  • Best Doctors® in America, 2005-2006
  • ASM BD Award for Research in Clinical Microbiology, American Society of Microbiology, 2007
  • Billy H. Cooper Award for Excellence in Clinical Mycology, Medical Mycology Society of America, 2007


  • Pathology - Anatomic & Clinical Pathology
  • Pathology - Medical Microbiology

Specialty Interests

Infectious disease pathology, molecular microbiology, Mycology and Parasitology

Awards & Honors

  • Cleveland Clinic Innovators Award 2002, Pan-Salmonella Broad Range PCR, 2004
  • Cleveland Clinic Innovators Award 2003, Identification of Mycobacteria by Pyrosequencing, 2004
  • Best Doctors® in America, 2005-2006 
  • Fellow, American Academy of Microbiology, 2004
  • Cleveland Clinic Innovators Award 2006, Integration PCR, 2006
  • Scholarship, CAP Spokesperson Training Program, 2006                
  • ASM BD Award for Research in Clinical Microbiology, American Society of Microbiology, 2007
  • Billy H. Cooper Award for Excellence in Clinical Mycology, Medical Mycology Society of America, 2007

Innovations & Patents

  • Identification of Histoplasma capsulatum using a PCR assay; Patent Number 20050065330
  • Single tube screen; Patent Number 20040241786
  • Identification of Salmonella using a PCR assay; Patent Number 20060177824


  • American Society for Microbiology
  • American Academy of Microbiology
  • College of American Pathologists
  • United States and Canadian Academy of Pathology
  • Royal Society of Tropical Medicine and Hygiene
Research & Publications

Research & Publications

See publications for Gary Procop, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/7/2021, Dr. Procop has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Fiduciary Role. Dr. Procop serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:

  • Next1 Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Related Videos Featuring Gary Procop, MD

Related Videos Featuring Gary Procop, MD

Back to Top